Skip to main content

Table 2 PD in minimum absorbed doses to 25%, 50%, and 75% (D25, D50, D75) of the lesion VOI volume compared against MC. The PD was formed per lesion and then averaged over all lesion giving the presented value

From: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T

Method

VSVsoft

Mean ± SD

\( {\mathbf{VSV}}_{\mathbf{weighted}}^{\mathbf{soft}} \)

Mean ± SD

VSVsoft+bone

Mean ± SD

\( {\mathbf{VSV}}_{\mathbf{weighted}}^{\mathbf{soft}+\mathbf{bone}} \)

Mean ± SD

PD of D25 [%]

15 ± 14

− 4 ± 2

− 36 ± 8

− 2 ± 2

PD of D50 [%]

17 ± 11

− 4 ± 2

− 35 ± 6

− 2 ± 2

PD of D75 [%]

18 ± 10

− 5 ± 1

− 34 ± 6

− 2 ± 1